Please note that we have stopped the regular imports of Gene Expression Omnibus (GEO) data into ArrayExpress. This may not be the latest version of this experiment.

E-GEOD-21281 - A critical role of microRNAs in human pulmonary arterial hypertension. miR-204: a novel therapeutic target (TaqMan qPCR)

Status
Released on 16 December 2010, last updated on 10 June 2014
Organism
Homo sapiens
Samples (4)
Array (1)
Protocols (3)
Description
Pulmonary arterial hypertension (PAH) is a vascular remodeling disease characterized by enhanced pulmonary artery smooth muscle cell (PASMC) proliferation and suppressed apoptosis. Downregulation of the BMPR2 gene along with activation of the transcription factor NFAT have been implicated in the maintenance of pro-proliferative and anti-apoptotic stages of cells. Since an increasing number of microRNAs have been implicated in the regulation of genes specifically important for cell proliferation and apoptosis, we hypothesized that microRNAs might be associated with these cellular features in the etiology of PAH. We demonstrate that downregulation of one such microRNA (miR-204) in human PAH-PASMC promotes the activation of an Src/STAT3/NFAT axis that increases PAH-PASMC proliferation and their resistance to apoptosis. Stimulation experiments using the pro-PAH factors (PDGF, endothelin-1 and angiotensin II) and time course analysis in experimental PAH show that STAT3 activation leads to miR-204 downregulation, thereby activating an Src-dependent positive feedback loop sustaining STAT3 and activating NFAT. More importantly, restoring miR-204 expression decreases proliferation and resistance to apoptosis in human and in an experimental PAH model. Taken together, our study uncovers a new STAT3-miR-204-Src/STAT3/NFAT axis that links the STAT3-dependent downregulation of BMPR2 with the NFAT-mediated pro-proliferative and anti-apoptotic phenotype observed in PAH. Our data point toward a novel potential strategy for treating patients with PAH. Comparative expression profiling of PAH versus healthy patients to evaluate the modulated genes in the disease. Following the demonstration of the downregulation of miR-204 in PAH we want to investigate the effect of the inhibition (using antagomir) of miR-204 expression in PASMC cells.
Experiment type
transcription profiling by RT-PCR 
Contacts
Eric R Paquet <eric.paquet@crhdq.ulaval.ca>, Audrey Courboulin, Jacques Côté, Martin J Simard, Nehmé Saksouk, Nellie J Giguère, Roxane Paulin, Sébastien Bonnet
Citation
Role for miR-204 in human pulmonary arterial hypertension. Courboulin A, Paulin R, Gigu�re NJ, Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher S, C�t� J, Simard MJ, Bonnet S. , PMID:21321078
MIAME
PlatformsProtocolsVariablesProcessedRaw
Files
Investigation descriptionE-GEOD-21281.idf.txt
Sample and data relationshipE-GEOD-21281.sdrf.txt
Raw data (1)E-GEOD-21281.raw.1.zip
Processed data (1)E-GEOD-21281.processed.1.zip
Array designA-GEOD-10305.adf.txt
Links